Mitral ve Triküspit Kapak Hastalıklarında Perkütan Tedavi

Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez- SaranoM. Burden of valvular heart diseases: a population-based study. Lancet. (2006) 368:1005–11. doi: 10.1016/S0140-6736(06)69208-8

Topilsky Y, Maltais S, Medina Inojosa J, Oguz D, Michelena H, Maalouf J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. (2018) 12:433–42. doi:10.1016/j.jcmg.2018.06.014

Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on valvular heart disease. Eur Heart J. 2003;24:1231–43.

Asgar AW, Mack MJ, Stone GW. Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol. 2015;65:1231–48.

Punnoose L, Burkhoff D, Cunningham L, Horn EM. Functional mitral regurgitation: therapeutic strategies for a ventricular disease. J Card Fail. 2014;20:252–67.

Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91.

Goldstein D, Gelijns AC, Moskowitz AJ. Surgery for severe ischemic mitral regurgitation. N Engl J Med. 2016;374:1992–3.

Fann JI, Goar FGS, Komtebedde J, Oz MC, Block PC, Foster E, et al. Beating Heart Catheter-Based Edge-to-Edge Mitral Valve Procedure in a Porcine Model: Efficacy and Healing Response. Circulation. 2004;110(8):988–93.

Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M, et al. The double-orifice technique in mitral valve repair: A simple solution for complex problems. J Thorac Cardiovasc Surg. 2001;122(4):674–81.

Feldman T, Foster E, Glower DD, Glower DG, Kar S, Rinaldi MJ, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011; 364(15):1395–406.

Lesevic H, Karl M, Braun D, Barthel P, Orban M, Pache J, et al. Longterm outcomes after MitraClip implantation according to the presence or absence of EVEREST inclusion criteria. Am J Cardiol. (2017) 119:1255– 61. doi: 10.1016/j.amjcard.2016.12.027

Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P, et al. Percutaneous mitral valve repair using the edge-to-edge technique: sixmonth results of the EVEREST Phase I Clinical Trial. J AmColl Cardiol. (2005) 46:2134–40. doi: 10.1016/j.jacc.2005.07.065

Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. (2015) 66:2844–54. doi: 10.1016/j.jacc.2015.10.018

Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, Lefèvre T, Piot C, Rouleau F, Carrié D, Nejjari M, Ohlmann P, Leclercq F, Saint Etienne C, Teiger E, Leroux L, Karam N, Michel N, Gilard M, Donal E, Trochu JN, Cormier B, Armoiry X, Boutitie F, Maucort-Boulch D, Barnel C, Samson G, Guerin P, Vahanian A, Mewton N; MITRA-FR Investigators. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation. N Engl J Med. 2018 Dec 13;379(24):2297-2306. doi: 10.1056/NEJMoa1805374.

Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ; COAPT Investigators. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med. 2018 Dec 13;379(24):2307-2318. doi: 10.1056/NEJMoa1806640.

Schofer J, Siminiak T, Haude M, Herrman JP, Vainer J, Wu JC, et al. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation. (2009) 120:326– 33. doi: 10.1161/CIRCULATIONAHA.109.849885

Siminiak T, Wu JC, Haude M, Hoppe UC, Sadowski J, Lipiecki J, et al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN trial. Eur J Heart Fail. (2012) 14:931–8. doi: 10.1093/eurjhf/hfs076

Rogers JH, Thomas M, Morice MC, Narbute I, Zabunova M, Hovasse T, et al. Treatment of heart failure with associated functional mitral regurgitation using the ARTO system: initial results of the first-in-human MAVERIC trial (Mitral Valve Repair Clinical Trial). JACC Cardiovasc Interv. (2015) 8:1095–104. doi: 10.1016/j.jcin.2015.04.012

Park YH, Chon MK, Lederman RJ, Sung SC, Je HG, Choo KS, et al. Mitral loop cerclage annuloplasty for secondary mitral regurgitation: first human results. JACC Cardiovasc Interv. (2017) 10:597–610. doi: 10.1016/j.jcin.2016.12.282

Yoon SH, Whisenant BK, Bleiziffer S, Delgado V, Dhoble A, Schofer N, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40:441–51.

Guerrero M, Urena M, Himbert D, Wang DD, Eleid M, Kodali S, et al. 1-year outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification. J Am Coll Cardiol. 2018;71:1841–53.

Khan JM, Babaliaros VC, Greenbaum AB, Foerst JR, Yazdani S, McCabe JM, et al. Anterior leaflet laceration to prevent ventricular outflow tract obstruction during transcatheter mitral valve replacement. J Am Coll Cardiol. 2019;73:2521–34.

Taramasso M, Vanermen H, Maisano F, Guidotti A, La Canna G, Alfieri O. The growing clinical importance of secondary tricuspid regurgitation. J Am Coll Cardiol. 2012;59:703–10.